חוב לטווח קצר להון Biofrontera (BFRI)

This chart on the GURU.Markets platform illustrates the price action of Biofrontera Inc. (BFRI), which currently stands at 0.09. Biofrontera Inc. (BFRI) dominates the skin light therapy niche, developing advanced LED systems and activation gels. High barriers to entry are secured by patents and FDA certification, while business stability is supported by the absence of political risks regarding shipments from Germany to the US.

Investors utilize this ratio to assess the debt load and the company's resilience to changes in borrowing costs. The metric compares short-term liabilities to equity, and the current short-term debt to equity value reflects the degree of financial leverage that Biofrontera Inc. (BFRI) can employ to modernize plants through the implementation of robotic packaging systems and AI control.